Rick Bodmer
Corporate Officer/Principal bei MUSTANG BIO, INC.
Ursprung des Netzwerks ersten Grades von Rick Bodmer
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 18 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Rick Bodmer
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Angelo, Gordon & Co. LP
Angelo, Gordon & Co. LP Investment ManagersFinance Angelo, Gordon & Co. LP (Angelo Gordon) is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Michael L. Gordon in 1988. They were acquired by TPG, Inc. (NASDAQ: TPG) in 2023. Angelo Gordon invests on behalf of pension funds, corporations, endowments, foundations, sovereign wealth funds and individuals. | Investment Managers | Portfolio Manager-Equities | |
ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Chief Executive Officer Director/Board Member | |
NATIONAL HOLDINGS CORPORATION | Investment Banks/Brokers | Chairman Director/Board Member | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Highbridge Capital Management LLC
Highbridge Capital Management LLC Investment ManagersFinance Highbridge Capital Management LLC (HCM Highbridge is a registered investment advisor and global alternative investment firm headquartered in New York City. The firm was founded in 1992 and is a subsidiary of JPMorgan Asset Management Holdings Inc., which is a wholly-owned subsidiary of JPMorgan Chase & Co. (NYSE: JPM). Highbridge manages capital for sophisticated investors, who include financial institutions, public and corporate pension funds, sovereign wealth funds, endowments and family offices. | Investment Managers | Portfolio Manager-Equities | |
MARKER THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Founder Chief Executive Officer | |
FORTRESS BIOTECH, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Chief Executive Officer | |
Stroock & Stroock & Lavan LLP
Stroock & Stroock & Lavan LLP Miscellaneous Commercial ServicesCommercial Services Stroock & Stroock & Lavan LLP provides legal services. It is a law firm, which provides transactional and litigation guidance to multinational corporations, investment banks & venture capital firms in the U.S. and abroad. Its practice areas include corporate finance and legal services to financial institutions, energy, financial restructuring, insurance, intellectual property, litigation, and real estate. The company was founded in 1876 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Charles River Laboratories Ashland LLC
Charles River Laboratories Ashland LLC Miscellaneous Commercial ServicesCommercial Services Charles River Laboratories Ashland LLC provides product safety and toxicological assessment research and services. It serves the international pharmaceutical, biotechnology, chemical, agricultural, veterinary, food, and consumer products industries. The firm's services include toxicology, discovery, ADME & DMPK, analytical and regulatory services, safety pharmacology, and pathology. The company was founded in 1976 and is headquartered in Ashland, OH. | Miscellaneous Commercial Services | Compliance Officer | |
The Johns Hopkins University | College/University | Undergraduate Degree | |
Monmouth University | College/University | Graduate Degree | |
Princeton University | College/University | Undergraduate Degree | |
University of Maryland | College/University | Graduate Degree | |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Doctorate Degree | |
Yeshiva University | College/University | Undergraduate Degree Undergraduate Degree | |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Hospital/Nursing Management | Director/Board Member | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Society of Quality Assurance | President | ||
American Friends of Shalva, Inc. | Corporate Officer/Principal | ||
Opus Point Partners Management LLC
Opus Point Partners Management LLC Investment ManagersFinance Opus Point Partners Management LLC (OPPM) is a hedge fund manager headquartered in New York City. The firm was founded by Lindsay Rosenwald and Michael Weiss in 2009. They are owned by Opus Point Partners LLC, which is a subsidiary of Weiss & Co. LLC. OPPM manages investments that are dedicated to healthcare and life science. | Investment Managers | Chief Executive Officer Founder | |
Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
Harvard Medical School | College/University | Corporate Officer/Principal | |
Kingsbrook Partners LP
Kingsbrook Partners LP Investment ManagersFinance Kingsbrook Partners LP is an independent hedge fund management firm headquartered in New York City. It was founded by Adam J. Chill, Scott M. Wallace and Ari J. Storch in 2009. The firm provides investment advice to high net worth clients. | Investment Managers | Founder | |
Columbia Law School | College/University | Graduate Degree Graduate Degree | |
American Brachytherapy Society | President | ||
Danforth Advisors LLC
Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Danforth Advisors LLC provides advisory services. It offers finance support and stratigic consultation services for life science firm. The company was founded by Gregg Beloff and Daniel Geffken and is headquartered in Southborough, MA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
Yale School of Medicine | College/University | Doctorate Degree | |
Carmel Academy, Inc. | College/University | Director/Board Member | |
ORIGO ACQUISITION CORP | Financial Conglomerates | Chief Executive Officer Chairman Director/Board Member Director/Board Member | |
CHECKPOINT THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Investor Relations Contact | |
AVENUE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Investor Relations Contact | |
LEGEND BIOTECH CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
Helocyte, Inc.
Helocyte, Inc. Miscellaneous Commercial ServicesCommercial Services Helocyte, Inc. engages in the development and commercialization of immunotherapies for the prevention and treatment of cytomegalovirus or CMV (cancer and infectious disease). It focuses on developing PepVax, a HLA-restricted single antigen peptide vaccine for controlling CMV in allogeneic hematopoietic stem cell transplant recipients and Triplex. The company was founded by Donald J. Diamond in 2015 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Cyprium Therapeutics, Inc.
Cyprium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Fortress Biotech, Inc., Cyprium Therapeutics, Inc. is an American New York-based company focused on developing novel therapies for the treatment of Menkes disease and related copper metabolism disorders. The company was granted FDA breakthrough therapy, fast track, and rare pediatric disease designations, as well as FDA orphan drug designation for both Cutx-101 and AAV-ATP7A. The European Medicines Agency also granted orphan drug designation to Cyprium. In March 2017, Cyprium entered into a cooperative research and development agreement with the Eunice Kennedy Shriver National Institute of Child Health and Human Development to advance the clinical development of Cutx-101 for the treatment of Menkes disease. In 2023, Cyprium completed the transfer of its proprietary rights and assigned its FDA documents pertaining to Cutx-101 to Sentynl Therapeutics, Inc. Cyprium and NICHD also previously entered into a worldwide, exclusive license agreement to develop and commercialize AAV-ATP7A gene therapy, which is currently in pre-clinical development. The company was founded in 2017 by Michael Sean Weiss, Lindsay Allan Rosenwald, and Lung S. Yam, who has been the CEO since then. | Miscellaneous Commercial Services | Founder Founder | |
Cellvation, Inc. | Chairman Director/Board Member | ||
JOURNEY MEDICAL CORPORATION | Pharmaceuticals: Major | Chairman Director/Board Member Investor Relations Contact | |
Caelum Biosciences, Inc.
Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | General Counsel | |
Baergic Bio, Inc.
Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Baergic Bio, Inc. develops therapeutic drugs for the treatment of central nervous system disorders. It offers oncology, rare diseases, and gene therapy. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
STANDARD BIOTOOLS INC. | Miscellaneous Commercial Services | Director of Finance/CFO |
Statistik
International
Vereinigte Staaten | 47 |
Schweiz | 2 |
Cayman Islands | 2 |
Vereinigtes Königreich | 2 |
Sektoral
Health Technology | 19 |
Consumer Services | 13 |
Finance | 8 |
Commercial Services | 7 |
Health Services | 3 |
Operativ
Director/Board Member | 42 |
Corporate Officer/Principal | 25 |
Chairman | 23 |
Director of Finance/CFO | 19 |
Chief Executive Officer | 15 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Michael Weiss | 25 |
Lindsay Rosenwald | 23 |
Neil Herskowitz | 22 |
Eliot Lurier | 13 |
Adam Chill | 11 |
James Murphy | 8 |
Susan E. Ward | 7 |
Manuel Litchman | 6 |
Michael Zelefsky | 6 |
Greg Furrow | 5 |
Albert Paszek | 5 |
Lynn E. Bayless | 5 |
Robert Sexton | 4 |
Jaclyn Jaffe | 4 |
Bruce Dezube | 4 |
- Börse
- Insiders
- Rick Bodmer
- Unternehmensverbindungen